The cumulative features conveyed in the IGF-IIsT group definition, we believe, may offer a biologically sounder context for both classification and future personalized molecular targeting strategies pointing at cancer-secreted IGF-II and its malignant-switch-specific intracellular signal as a widely evidence-based target over any of its individual receptors. This evidence concerns the gene IGF2 and cancer.